Special Warrants Convert into 6% Unsecured Convertible Debentures at $6.50 Per Common Share
Special Warrants Convert into 6% Unsecured Convertible Debentures at $6.50 Per Common Share
Algae Dynamics this morning said the company, together with the University of Western Ontario, received project funding in the form of a C$400,000 grant from Mitacs
The companies also aim to create a level of effective transparency in an industry where tracking transactions is a critical part of assuring compliance.
Mr. Rick Fitzgerald brings extensive strategic marketing and senior leadership in the alcoholic beverage and tobacco industries to the Board of Directors. Dr. Michael Bumby brings extensive financial, international and capital markets experience to the executive team as Chief Financial Officer
ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) today announced that it has added Mr. Rick Fitzgerald to the Board of Directors and Dr. Michael Bumby to the executive team as Chief Financial Officer.
Algae Dynamics (OTC: ADYNF), developer of unique health products infused with cannabis and algae oils, has received an investment of $250,000 from Teewinot Life Sciences Corporation
Global Payout this morning said that its majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), is exploring potential strategic partnership opportunities in the cannabis banking sector.
Aurora Cannabis Executes Lock-up Agreements with 38% of CanniMed Shareholders
Shareholders advised to take no action at this time. Details regarding acquisition transaction to be forthcoming.
Grey Cloak Tech (OTCQB: GRCK) announced today that is has purchased the domain CBD.co.
Aurora Cannabis elects to exercise its right under the warrant indenture governing the common share purchase warrants of the Company issued on February 28, 2017
SinglePoint (OTC: SING) this morning announced the soft launch of a bitcoin exchange that can be utilized by any business.
Canopy reports second quarter loss, but revenue increases.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) breakthrough biosynthesis process allows it to control the entire drug development process, in house – and without the inherent challenges of traditional agricultural cultivation methods.
Insider Financial looks at the recent market run by InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF)